SciSparc SPRC 深 沪
等待开盘 10-07 09:30:00 美东时间
4.33
-0.030
-0.69%
华盛通- 最 高4.4627
- 今 开4.40
- 成交量 6157股
- 最 低 4.20
- 昨 收 4.36
- 总市值 251.56万
- 52周最高 40.41
- 市盈率 静 --
- 换手率 1.06%
- 52周最低 2.98
- 委 比 93.87%
- 总股本 58.10万
- 历史最高 34791.12
- 量 比 0.66
- 振 幅 6.03%
- 历史最低 4.1589
- 每 手 1
- 风险率 9.32%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多SciSparc Says NeuroThera Labs Advances Participant Enrollment For Clinical Trial Assessing SCI-210 Treatment For Symptoms Associated With Autism Spectrum Disorder
SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), today announced that NeuroThera Labs Inc. (TSXV:NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system disorders, continued advancement in participant enrollment for the ...
09-01 04:04
NeuroThera Labs announces 1-for-14 share consolidation
NeuroThera Labs (NTLX:CA), a subsidiary of SciSparc, will consolidate its common shares on a 1-for-14 basis. The consolidation is expected to take effect at market open on or around September 2, 2026,...
08-29 05:14
SciSparc Unit Neurothera Labs And Clearmind Medicine Publish U.S. Patent Application For A Novel Combination Of 3,4-Methylenedioxymethamphetamine And N-Acylethanolamines For Use In Methods Of Treating Post-Traumatic Stress Disorder, Anxiety And Eating Disorders
SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), today announced that its subsidiary, NeuroThera Labs Inc. (TSXV:NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system disorders, ,today announced that its ongoing collabo...
08-24 20:54
What's Going On With SciSparc Shares On Friday?
SciSparc Ltd. (NASDAQ:SPRC) shares are down more than 20% on Friday. On Wednesday, the company disclosed advancements in its quantum platform for clinical data analytics. This news comes amid a generally positive tone in the broader market, with S&P 500 futures gaining about 0.4%. • SciSparc shares ...
07-31 22:22
SciSparc's NeuroThera Labs Subsidiary Completes Internal Validation Of Quantum Sampling Workflow Developed Platform For Clinical Trials Data Analysis
SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), today announced that NeuroThera Labs Inc. (TSXV:NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system disorders, has successfully completed internal validation of a propri...
07-29 20:36
SciSparc’s subsidiary NeuroThera Labs Initiates Phase IIb Clinical Trial Site At Hannover Medical School In Germany For SCI-110, Proprietary Cannabinoid-Based Treatment Candidate For Tourette Syndrome In Adults
SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), today announced that its subsidiary NeuroThera Labs Inc. (TSXV:NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system disorders, announced the initiation of its Phase IIb c...
07-15 21:00
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers PRF Technologies (NASDAQ:PRFX) stock rose 231.0% to $4.54 during Frida...
05-30 01:06
Why Is SciSparc Stock Skyrocketing On Thursday?
Discover why SciSparc Ltd. (NASDAQ: SPRC) stock is surging today after subsidiary NeuroThera Labs receives TSX approval for a key majority stake acquisition.
05-29 00:28
SciSparc shares are trading higher after the company announced its subsidiary NeuroThera Labs received conditional TSX approval for the acquisition of approximately 54% of interest in CliniQuantum.
SciSparc shares are trading higher after the company announced its subsidiary N...
05-28 21:20
SciSparc Regains Conditional Nasdaq Compliance After Equity Shortfall
SciSparc Ltd. ( ($SPRC) ) just unveiled an update. On January 12, 2026, SciSpar...
05-11 20:29
